当前位置：首页 > 文献互助 > 互助详情

Efficacy, safety, and biomarker analysis of neoadjuvant camrelizumab plus apatinib as a chemotherapy-free strategy for early-stage triple-negative breast cancer: a phase II study复制

用户EO9nReo4Hj6s 57分钟前 17 10 已完结

1. 当前求助状态已完结, 请及时下载应助文件

2. 系统将在 2026-09-11 14:42:41 删除文件

注: 所有应助的资源仅供学习交流使用, 不得违反相关法律法规

DOI: 10.1007/s10549-026-08066-5复制

文献链接: https://link.springer.com/10.1007/s10549-026-08066-5复制

其他信息:

出版社: Springer Science and Business Media LLC
作者: Zhenluan Tian; Hengyu Li; Yuxin Deng; Herui Yao; Ying Wang; Liang Jin; Heran Deng; Na Chen; Jieqiong Liu
全文下载地址: https://link.springer.com/content/pdf/10.1007/s10549-026-08066-5.pdf

上一篇：Effect of Rivoceranib 200 mg Once Daily on the Pharmacokinetics of a Cocktail Probe Substrate of Cytochrome P450 Enzymes: A Phase I Trial in Healthy Volunteers

下一篇：COL1A1 modulates apatinib sensitivity through promoting glycolysis and angiogenesis in gastric cancer cells

互助时间线

2026-09-04 14:53:47 [完结求助]

楼主确认了小白兔456应助的文件是正确的, 求助状态变成 已完结

2026-09-04 14:42:41 [上传文件]

小白兔456上传了文件(pdf 1.20 MB), 求助状态变成 待确认

2026-09-04 14:34:35 [发起求助]

最新发布的求助

Biomarker-Stratified Phase II Trial of Trastuzumab Rezetecan in Advanced Salivary Gland Carcinoma Across Cohorts With High and Low Human Epidermal Growth Factor Receptor 2 Expression 8分钟前
Synthesis of Mesoporous Catechin Nanoparticles as Biocompatible Drug-Free Antibacterial Mesoformulation 17分钟前
Preparation and properties of some organotin compounds : I. Dibutyltin glycolates 21分钟前
TMEM184A-mediated autophagy in MHC-I degradation promotes tumor immune evasion 28分钟前
Efficacy and safety of once-weekly semaglutide 2·4 mg in Chinese adults with overweight or obesity (STEP 12): a randomised, double-blind, placebo-controlled, multicentre, phase 3b trial 36分钟前
Clinical Efficacy and Influencing Factors of Apatinib Combined With Sintilimab in the Treatment of Advanced Non‐Small‐Cell Lung Cancer 53分钟前
COL1A1 modulates apatinib sensitivity through promoting glycolysis and angiogenesis in gastric cancer cells 55分钟前
Efficacy, safety, and biomarker analysis of neoadjuvant camrelizumab plus apatinib as a chemotherapy-free strategy for early-stage triple-negative breast cancer: a phase II study 57分钟前
Effect of Rivoceranib 200 mg Once Daily on the Pharmacokinetics of a Cocktail Probe Substrate of Cytochrome P450 Enzymes: A Phase I Trial in Healthy Volunteers 1小时前
Sutetinib for Patients with Non-Small Cell Lung Cancer Harboring Uncommon EGFR Mutations: A Multicenter, Open-Label, Phase IIb Trial 1小时前
Causes, Risk Analysis, and Countermeasures of Urban Road Collapse in China from 2019 to 2020 1小时前
Post-herpetic neuralgia 1小时前

wispass工作室 Copyright © 蜀ICP备2024051606号-2 www.wispass.com